Skip to content

Increase in the effectiveness of inhaled salbutamol by supportive use of electrical impedance tomography in ventilated patients

Increase in the effectiveness of inhaled salbutamol by supportive use of electrical impedance tomography in ventilated patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014706
Enrollment
80
Registered
2018-05-14
Start date
2019-01-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mechanical ventilation J44.1

Interventions

Group 1: Intervention group with optimization of respirator setting by use of EIT prior to salbutamol nebulization Group 2: Control group with salbutamol nebulization without EIT optimization

Sponsors

Universitätsklinikum Knappschaftskrankenhaus BochumKlinik für Anästhesiologie, Intensivmedizin und Schmerzmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -ICU patients with a known obstructive pulmonary disease and / or an acute obstructive problem -Patient care (ward): interdisciplinary, operative, intensive care unit -Age> 18 years -Female or Male - ventilated patients with a Horovitz index <400, and a study-independent medical indication for salbutamol nebulization in obstructive pulmonary disease and / or an acute obstructive disease. -written consent or positive vote of a independent consultant

Exclusion criteria

Exclusion criteria: -Intensive patients with no medical indication and / or contraindication for inhaled salbutamol administration -Age 35) -Pre-existing conditions and operations: patients with chest trauma or surgery (e.g. pneumectomy), or other lung diseases (e.g. ARDS, pneumonia), ECMO therapy, neuromuscular diseases, severe cardiac diseases (eg NYHA III-IV), acute ischemic events, active implants (eg pacemakers, ICD) or thoracic skin lesions and wound dressings Refusal by patient, legal representative or consultant Patients with known salbutamol intolerance, existing pregnancy or lactation, long-term ventilation> 14 days, do-not-resuscitate order

Design outcomes

Primary

MeasureTime frame
This study evaluates the change of airway resistance 30 minutes after salbutamol inhalation and prior use of electrical chest impedance tomography (EIT) for optimization of the respirator setting

Secondary

MeasureTime frame
Before and 30 minutes after salbutamol inhalation: - Changes made in respirator setting under EIT: Pinsp, PEEP, inspiration-expiration-ration, inspiratory time, respiratory rate, ventilation mode) - assessment of changes in tidal volume, alveolar pressures, compliance, arterial oxygen partial pressure (paO2), Horovitz index, arterial carbon dioxide partial pressure (paCO2), peripheral and arterial oxygen saturation, lower and upper inflection point of the pressure-volume curve, - Region of Interest (ROI), end-expiratory trend (deltaEELI) 30-day mortality mechanical ventilation duration of ICU treatment Hospital treatment period resumption rate on ICU

Countries

Germany

Contacts

Public ContactTim Rahmel

Universitätsklinikum Knappschaftkrankenhaus Bochum GmbHKlinik für Anästhesiologie, Intensivmedizin und Schmerztherapie

tim.rahmel@kk-bochum.de0234/299-3001

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 21, 2026